Skip to main content

Research Repository

Advanced Search

Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study

Abhishek, Abhishek; Jenkins, Wendy; La-Crette, Jonathan; Fernandes, Gwen Sascha; Doherty, Michael

Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study Thumbnail


Authors

Wendy Jenkins

Jonathan La-Crette

Gwen Sascha Fernandes

Michael Doherty



Abstract

Objectives: To evaluate the persistence and adherence on urate-lowering treatment (ULT) in primary care 5 years after an initial nurse-led treatment of gout.

Methods: One hundred gout patients initiated on up-titrated ULT between March and July 2010 were sent a questionnaire that elicited information on current ULT, reasons for discontinuation of ULT if applicable, medication adherence and generic and disease-specific quality-of-life measures in 2015. They were invited for one visit at which height and weight were measured and blood was collected for serum uric acid measurement.

Results: Seventy-five patients, mean age 68.13 years ( s . d . 10.07) and disease duration 19.44 years ( s . d . 13), returned completed questionnaires. The 5-year persistence on ULT was 90.7% (95% CI 81.4, 91.6) and 85.3% of responders self-reported taking ULT ⩾6 days/week. Of the 65 patients who attended the study visit, the mean serum uric acid was 292.8 μmol/l ( s . d . 97.2).

Conclusion: An initial treatment that includes individualized patient education and involvement in treatment decisions results in excellent adherence and persistence on ULT >4 years after the responsibility of treatment is taken over by the patient's general practitioner, suggesting that this model of gout management should be widely adopted.

Citation

Abhishek, A., Jenkins, W., La-Crette, J., Fernandes, G. S., & Doherty, M. (2016). Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology, 56(4), https://doi.org/10.1093/rheumatology/kew395

Journal Article Type Article
Acceptance Date Aug 26, 2016
Publication Date Dec 12, 2016
Deposit Date Apr 6, 2018
Publicly Available Date Mar 28, 2024
Journal Rheumatology
Electronic ISSN 1462-0332
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 56
Issue 4
DOI https://doi.org/10.1093/rheumatology/kew395
Keywords gout, urate lowering treatment, persistence, adherence
Public URL https://nottingham-repository.worktribe.com/output/833843
Publisher URL https://academic.oup.com/rheumatology/article/56/4/529/2671019
Related Public URLs https://www.ncbi.nlm.nih.gov/pubmed/28082620
Additional Information This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Abhishek Abhishek, Wendy Jenkins, Jonathan La-Crette, Gwen Fernandes, Michael Doherty; Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care—5-year follow-up of a proof-of-concept study, Rheumatology, Volume 56, Issue 4, 1 April 2017, Pages 529–533 is available online at: https://academic.oup.com/rheumatology/article/56/4/529/2671019.